Published in Ann Surg on July 01, 1991
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
Cyclosporine. N Engl J Med (1989) 5.67
A radioimmunoassay to measure cyclosporin A in plasma and serum samples. J Immunoassay (1981) 2.55
Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med (1984) 2.10
The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int (1988) 1.34
Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone. Transplantation (1989) 1.12
Calculations on long-term graft and patient survival in human kidney transplantation. Transplant Proc (1977) 1.10
Important risk factors of allograft survival in cadaveric renal transplantation. A study of 426 patients. Ann Surg (1988) 1.03
A controlled trial of cyclosporine in renal transplantation with conversion to azathioprine and prednisolone after three months. Transplantation (1983) 1.00
Kidney retransplantation in the cyclosporine era. Transplantation (1988) 0.93
Experience with cyclosporine and steroids in clinical renal transplantation. Ann Surg (1984) 0.92
Long-term results of cyclosporine treatment in renal transplantation. Transplant Proc (1986) 0.89
Monoclonal antibody treatment of human allograft recipients. Surg Gynecol Obstet (1988) 0.88
Associations between cyclosporine therapy and interstitial fibrosis in renal allograft biopsies. Transplantation (1988) 0.82
Conversion from cyclosporine to azathioprine in renal allograft recipients. Transplantation (1984) 0.82
Cyclosporine mono-drug therapy. Transplant Proc (1988) 0.81
Cyclosporine toxicity: the effect of combined therapy using cyclosporine, azathioprine, and prednisone. Am J Kidney Dis (1987) 0.81
A controlled prospective trial of triple therapy with low-dose azathioprine, cyclosporine, and methylprednisolone in renal transplantation. Transplant Proc (1987) 0.79
Repeat cadaver kidney transplantation using cyclosporine A immunosuppression. J Urol (1987) 0.78
Pharmacologic and immunologic agonists and antagonists of cyclosporine. Transplant Proc (1988) 0.78
A prospective randomized trial of matching for HLA-A and B versus HLA-DR in renal transplantation. Transplantation (1984) 0.77
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med (2000) 11.90
Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science (2000) 9.92
A compendium of gene expression in normal human tissues. Physiol Genomics (2001) 5.66
Customised antenatal growth charts. Lancet (1992) 5.34
Transmission of hepatitis C virus by organ transplantation. N Engl J Med (1991) 5.17
The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med (1993) 4.88
Comparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patients. Sleep Med (2001) 4.67
The Human Connectome Project: a data acquisition perspective. Neuroimage (2012) 4.64
Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L. EMBO J (1997) 4.53
T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature (1990) 4.40
Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol (2001) 4.06
Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity (1997) 4.05
Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain (2005) 3.99
An adjustable fetal weight standard. Ultrasound Obstet Gynecol (1995) 3.70
Uncertainty in xenotransplantation: individual benefit versus collective risk. Nat Med (1998) 3.54
Preoperative renal risk stratification. Circulation (1997) 3.47
Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg (1968) 3.34
Renal transplantation. N Engl J Med (1994) 3.33
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest (1987) 3.29
B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity (1997) 3.22
Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med (1999) 3.17
Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med (1995) 3.13
Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet (1996) 3.02
Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content. J Exp Med (1983) 2.94
Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med (1994) 2.93
Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development (1999) 2.89
Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med (1992) 2.78
Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. Kidney Int (2006) 2.76
Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med (1999) 2.74
Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol (1996) 2.71
Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol (1986) 2.68
Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS (2000) 2.61
Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am J Transplant (2007) 2.61
Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock (1991) 2.49
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med (1995) 2.48
Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci (1992) 2.47
Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med (1991) 2.46
Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA (2000) 2.35
Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. N Engl J Med (1972) 2.33
The evaluation of renal transplant candidates: clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians. J Am Soc Nephrol (1995) 2.32
IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat Med (2001) 2.29
The relationship between specific tissue lesions and pain severity in persons with knee osteoarthritis. Osteoarthritis Cartilage (2006) 2.27
Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol (1993) 2.27
Plasma membrane proton ATPase Pma1p requires raft association for surface delivery in yeast. Mol Biol Cell (2001) 2.27
Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines. J Immunol (1984) 2.26
Cardiotocography only versus cardiotocography plus PR-interval analysis in intrapartum surveillance: a randomised, multicentre trial. FECG Study Group. Lancet (2000) 2.22
Current therapy for cutaneous melanoma. J Am Acad Dermatol (1995) 2.19
Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int (2000) 2.19
Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med (1987) 2.16
Initiation of dialysis. J Am Soc Nephrol (1995) 2.16
The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer (1994) 2.14
The events of primary T cell activation can be staged by use of Sepharose-bound anti-T3 (64.1) monoclonal antibody and purified interleukin 1. J Immunol (1985) 2.14
Dose of hemodialysis and survival: differences by race and sex. JAMA (1998) 2.08
Cytomegalovirus infection after renal allotransplantation. JAMA (1967) 2.08
Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs. Nat Neurosci (2001) 2.04
Cyclosporine: a new immunosuppressive agent for organ transplantation. Ann Intern Med (1984) 2.03
Limitations of the facility-specific standardized mortality ratio for profiling health care quality in dialysis. Am J Kidney Dis (2001) 2.03
Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase. Proc Natl Acad Sci U S A (1972) 2.01
Health services needs of children in day care centers. Am J Public Health (1978) 1.95
Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat Neurosci (1999) 1.94
Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst (1996) 1.93
The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicity. J Exp Med (1973) 1.92
Prevalence and associations of epiretinal membranes. The Blue Mountains Eye Study, Australia. Ophthalmology (1997) 1.91
Genes involved in sister chromatid separation and segregation in the budding yeast Saccharomyces cerevisiae. Genetics (2001) 1.89
Suspected iron dextran-related adverse drug events in hemodialysis patients. Am J Kidney Dis (2001) 1.85
Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro. Proc Natl Acad Sci U S A (1972) 1.85
Further investigations on the mode of entry of vaccinia virus into cells. J Gen Virol (1976) 1.85
Secondary structure predictions and medium range interactions. Biochim Biophys Acta (1987) 1.84
Identity and cytotoxic capacity of cells infiltrating renal allografts. N Engl J Med (1975) 1.82
Survival of patients undergoing chronic hemodialysis and renal transplantation. N Engl J Med (1973) 1.74
Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J Immunol (1987) 1.73
Updated gestational age specific birth weight, crown-heel length, and head circumference of Chinese newborns. Arch Dis Child Fetal Neonatal Ed (2003) 1.72
HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry. Transplantation (1997) 1.71
Serum complement component levels in human glomerulonephritis. Ann Intern Med (1971) 1.70
Oncocytes, oncocytosis, and oncocytic tumors. Pathol Annu (1992) 1.69
Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions. N Engl J Med (1976) 1.69
Multiple milia during treatment with acitretin for mycosis fungoides. Acta Derm Venereol (1993) 1.68
Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med (1983) 1.68
Cardiac arrest and sudden death in dialysis units. Kidney Int (2001) 1.67
Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis (2000) 1.67
Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am J Transplant (2007) 1.64
Quality-of-life evaluation using Short Form 36: comparison in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis (2000) 1.60
Novel genes involved in endosomal traffic in yeast revealed by suppression of a targeting-defective plasma membrane ATPase mutant. J Cell Biol (1997) 1.60
Small bowel transplantation. Transplantation (1984) 1.59
A fish oil diet rich in eicosapentaenoic acid reduces cyclooxygenase metabolites, and suppresses lupus in MRL-lpr mice. J Immunol (1985) 1.58
Controlled trial of fetal intensive care. Am J Obstet Gynecol (1976) 1.57
A randomized prospective study of laparoscopy and laparotomy in the management of benign ovarian masses. Am J Obstet Gynecol (1997) 1.57
Renal transplantation in the inbred rat. 3. A study of heterologous anti-thymocyte sera. J Exp Med (1967) 1.57
The effect of povidone-iodine solution applied at the conclusion of ophthalmic surgery. Am J Ophthalmol (1995) 1.56
Rapamycin induces transforming growth factor-beta production by lymphocytes. Transplantation (2000) 1.56
Exploring the reverse J-shaped curve between urea reduction ratio and mortality. Kidney Int (1999) 1.56